Severe immune hemolytic anemia associated with prophylactic use of cefotetan in obstetric and gynecologic procedures

Authors
Garratty, G Leger, RM Arndt, PA
Citation
G. Garratty et al., Severe immune hemolytic anemia associated with prophylactic use of cefotetan in obstetric and gynecologic procedures, AM J OBST G, 181(1), 1999, pp. 103-104
Citations number
3
Categorie Soggetti
Reproductive Medicine","da verificare
Journal title
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
ISSN journal
00029378 → ACNP
Volume
181
Issue
1
Year of publication
1999
Pages
103 - 104
Database
ISI
SICI code
0002-9378(199907)181:1<103:SIHAAW>2.0.ZU;2-S
Abstract
Second- and third-generation cephalosporins, especially cefotetan, are incr easingly associated with severe, sometimes fatal immune hemolytic anemia. W e noticed that 10 of our 35 cases of cefotetan-induced hemolytic anemias we re in patients who had received cefotetan prophylactically for obstetric an d gynecologic procedures. Eight of these cases of severe immune hemolytic a nemia are described.